Skip Navigation


Brain Advance Access originally published online on April 18, 2006
Brain 2006 129(6):1446-1455; doi:10.1093/brain/awl096
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
129/6/1446    most recent
awl096v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (23)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Atsuta, N.
Right arrow Articles by Sobue, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Atsuta, N.
Right arrow Articles by Sobue, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2006). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients

Naoki Atsuta1, Hirohisa Watanabe1, Mizuki Ito1, Haruhiko Banno1, Keisuke Suzuki1, Masahisa Katsuno1, Fumiaki Tanaka1, Akiko Tamakoshi2 and Gen Sobue1

1 Departments of Neurology, Nagoya University Graduate School of Medicine Nagoya, Japan 2 Preventive Medicine/Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine Nagoya, Japan

Correspondence to: Gen Sobue, MD, Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan E-mail: sobueg{at}med.nagoya-u.ac.jp

Spinal and bulbar muscular atrophy (SBMA) is an adult-onset motoneuron disease caused by a CAG-repeat expansion in the androgen receptor (AR) gene and for which no curative therapy exists. However, since recent research may provide opportunities for medical treatment, information concerning the natural history of SBMA would be beneficial in planning future clinical trials. We investigated the natural course of SBMA as assessed by nine activities of daily living (ADL) milestones in 223 Japanese SBMA patients (mean age at data collection = 55.2 years; range = 30–87 years) followed from 1 to 20 years. All the patients were diagnosed by genetic analysis. Hand tremor was an early event that was noticed at a median age of 33 years. Muscular weakness occurred predominantly in the lower limbs, and was noticed at a median age of 44 years, followed by the requirement of a handrail to ascend stairs at 49, dysarthria at 50, dysphagia at 54, use of a cane at 59 and a wheelchair at 61 years. Twenty-one of the patients developed pneumonia at a median age of 62 and 15 of them died at a median age of 65 years. The most common cause of death in these cases was pneumonia and respiratory failure. The ages at onset of each ADL milestone were strongly correlated with the length of CAG repeats in the AR gene. However CAG-repeat length did not correlate with the time intervals between each ADL milestone, suggesting that although the onset age of each ADL milestone depends on the CAG-repeat length in the AR gene, the rate of disease progression does not. The levels of serum testosterone, an important triggering factor for polyglutamine-mediated motoneuron degeneration, were maintained at relatively high levels even at advanced ages. These results provide beneficial information for future clinical therapeutic trials, although further detailed prospective studies are also needed.

Key Words: natural history; motoneuron disease; SBMA; Kennedy disease; ADL milestone

Abbreviations: ADL, activities of daily living; ALT, alanine aminotransferase; AR, androgen receptor; AST, aspartate aminotransferase; CK, creatine kinase; HbA1c, haemoglobin A1c; SBMA, spinal and bulbar muscular atrophy

Received January 11, 2006. Revised March 19, 2006. Accepted March 23, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BrainHome page
L. E. Rhodes, B. K. Freeman, S. Auh, A. D. Kokkinis, A. La Pean, C. Chen, T. J. Lehky, J. A. Shrader, E. W. Levy, M. Harris-Love, et al.
Clinical features of spinal and bulbar muscular atrophy
Brain, October 21, 2009; (2009) awp258v1.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. J. Thurtell, E. P. Pioro, and R. J. Leigh
ABNORMAL EYE MOVEMENTS IN KENNEDY DISEASE
Neurology, April 28, 2009; 72(17): 1528 - 1530.
[Full Text] [PDF]


Home page
BrainHome page
K. Suzuki, M. Katsuno, H. Banno, Y. Takeuchi, N. Atsuta, M. Ito, H. Watanabe, F. Yamashita, N. Hori, T. Nakamura, et al.
CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA
Brain, January 1, 2008; 131(1): 229 - 239.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. Adachi, M. Waza, K. Tokui, M. Katsuno, M. Minamiyama, F. Tanaka, M. Doyu, and G. Sobue
CHIP Overexpression Reduces Mutant Androgen Receptor Protein and Ameliorates Phenotypes of the Spinal and Bulbar Muscular Atrophy Transgenic Mouse Model
J. Neurosci., May 9, 2007; 27(19): 5115 - 5126.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.